News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Travanti Pharma Inc. Raises $7.5 Million Series B Funding



7/27/2006 12:30:49 PM

Mendota Heights, Minnesota--Travanti Pharma Inc., a privately held company that develops and markets innovative drug delivery platforms announces it has raised $7.5 Million in Series B Funding.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES